Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study

References

• Haas EJ, Angulo FJ, McLaughlin JM, Anis, E, Singer, SR, Khan, F, Brooks, N, Smaja, M, Mircus, G, Pan, K, Southern, J. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–10. doi:10.1016/S0140-6736(21)00947-8.
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O’Doherty M, Brown K. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O’Brien KL, Smith PG, Wilder-Smith A. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924–44. doi:10.1016/S0140-6736(22)00152-0.
   PubMed Web of Science ®Google Scholar
• Gram MA, Emborg HD, Schelde AB, Friis NU, Nielsen KF, Moustsen-Helms IR, Legarth R, Lam JU, Chaine M, Malik AZ, Rasmussen M. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: a nationwide Danish cohort study. PLoS Med. 2022;19(9):e1003992. doi:10.1371/journal.pmed.1003992.
   PubMed Web of Science ®Google Scholar
• Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, Enever Y. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021;398(10318):2258–76. doi:10.1016/S0140-6736(21)02717-3.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kirsebom F, Toffa S, Sachdeva R, Gower C, Ramsay M, Lopez Bernal J. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28(4):831–7. doi:10.1038/s41591-022-01699-1.
   PubMed Web of Science ®Google Scholar
• Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D, Yaron S. BNT162b2 vaccine booster and mortality due to Covid-19. N Engl J Med. 2021;385(26):2413–20. doi:10.1056/NEJMoa2115624.
   PubMed Web of Science ®Google Scholar
• Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao L. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–53. doi:10.1038/s41562-021-01122-8.
   PubMed Web of Science ®Google Scholar
• Kraft KB, Godoy AA, Vinjerui KH, Kour P, Kjollesdal MKR, Indseth T. COVID-19 vaccination coverage by immigrant background. Tidsskr Nor Laegeforen. 2022;141(2). doi:10.4045/tidsskr.21.0799.
   PubMedGoogle Scholar
• Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Ng N, Leach S, Gisslén M, Hammar N, Nyberg F, et al. An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: a nationwide register-based study in Sweden. Vaccine. 2022;40(46):6640–8. doi:10.1016/j.vaccine.2022.09.065.
   PubMed Web of Science ®Google Scholar
• Spetz M, Lundberg L, Nwaru C, Li H, Santosa A, Leach S, Gisslén M, Hammar N, Rosvall M, Nyberg F. The social patterning of Covid-19 vaccine uptake in older adults: a register-based cross-sectional study in Sweden. Lancet Reg Health Eur. 2022;15:100331. doi:10.1016/j.lanepe.2022.100331.
   PubMedGoogle Scholar
• Dolby T, Finning K, Baker A, Fowler-Dowd L, Khunti K, Razieh C, Yates T, Nafilyan V. Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study. J Epidemiol Community Health. 2022;76(7):646–52. doi:10.1136/jech-2021-218415.
   PubMed Web of Science ®Google Scholar
• Perry M, Akbari A, Cottrell S, Gravenor MB, Roberts R, Lyons RA, Bedston S, Torabi F, Griffiths L. Inequalities in coverage of COVID-19 vaccination: a population register based cross-sectional study in Wales, UK. Vaccine. 2021;39(42):6256–61. doi:10.1016/j.vaccine.2021.09.019.
   PubMed Web of Science ®Google Scholar
• Kriss JL, Hung MC, Srivastav A, Black CL, Lindley MC, Lee JT, Koppaka R, Tsai Y, Lu PJ, Yankey D, Elam-Evans LD. COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020–November 2021. MMWR Morb Mortal Wkly Rep. 2022;71(23):757–63. doi:10.15585/mmwr.mm7123a2.
   PubMed Web of Science ®Google Scholar
• Gertz A, Rader B, Sewalk K, Brownstein JS. Emerging socioeconomic disparities in COVID-19 vaccine second-dose completion rates in the United States. Vaccines (Basel). 2022;10(1). doi:10.3390/vaccines10010121.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. Sage working group on vaccine hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Paul E, Fancourt D. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: an observational study of 22,139 fully vaccinated adults in the UK. Lancet Reg Health Eur. 2022;14:100317. doi:10.1016/j.lanepe.2022.100317.
   PubMedGoogle Scholar
• Agaku IT, Adeoye C, Long TG. Geographic, occupational, and sociodemographic variations in uptake of COVID-19 booster doses among fully vaccinated US adults, December 1, 2021, to January 10, 2022. JAMA Netw Open. 2022; 5(8):e2227680. doi:10.1001/jamanetworkopen.2022.27680.
   PubMed Web of Science ®Google Scholar
• Mody A, Bradley C, Redkar S, Fox B, Eshun-Wilson I, Hlatshwayo MG, Trolard A, Tram KH, Filiatreau LM, Thomas F, Haslam M. Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: a population-level analysis in St. Louis and Kansas City, Missouri. PLoS Med. 2022;19(8):e1004048. doi:10.1371/journal.pmed.1004048.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Health 2020. A European policy framework and strategy for the 21st century. Copenhagen: WHO; 2013.
   Google Scholar
• Drefahl S, Wallace M, Mussino E, Aradhya S, Kolk M, Brandén M, Malmberg B, Andersson G. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun. 2020;11(1):5097. doi:10.1038/s41467-020-18926-3.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. doi:10.1038/s41586-020-2521-4.
   PubMed Web of Science ®Google Scholar
• Indseth T, Grosland M, Arnesen T, Skyrud K, Kløvstad H, Lamprini V, Telle K, Kjøllesdal M. COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: a register-based study. Scand J Public Health. 2021;49(1):48–56. doi:10.1177/1403494820984026.
   PubMed Web of Science ®Google Scholar
• Kraft KB, Elgersma IH, Labberton AS, Indseth T, Godøy A. COVID-19: persons tested, confirmed cases and associated hospitalizations by education and income. Oslo: Norwegian Institute of Public Health; 2021.
   Google Scholar
• Skjesol I, Tritter JQ. The Norwegian way: COVID-19 vaccination policy and practice. Health Policy Technol. 2022;11(2):100635. doi:10.1016/j.hlpt.2022.100635.
   PubMed Web of Science ®Google Scholar
• Eurostat. [accessed 2022 Nov 1]. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Glossary:Equivalised_income.
   Google Scholar
• Norwegian Institute of Public Health. [accessed 2022 Nov 1]. https://www.fhi.no/en/id/infectious-diseases/coronavirus/daily-reports/daily-reports-COVID19/#by-municipality.
   Google Scholar
• de Lusignan S, Dorward J, Correa A, Jones N, Akinyemi O, Amirthalingam G, Andrews N, Byford R, Dabrera G, Elliot A, Ellis J. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034–42. doi:10.1016/S1473-3099(20)30371-6.
   PubMed Web of Science ®Google Scholar
• Labberton AS, Godoy A, Elgersma IH, Strand BH, Telle K, Arnesen T, Nygård KM, Indseth T. SARS-CoV-2 infections and hospitalisations among immigrants in Norway-significance of occupation, household crowding, education, household income and medical risk: a nationwide register study. Scand J Public Health. 2022;50(6):772–81. doi:10.1177/14034948221075029.
   PubMedGoogle Scholar
• Nystad W, Hjellvik V, Larsen IK, Ariansen I, Helland E, Johansen KI, Gulbrandsen J, Gulseth HL, Eide HN, Håberg SE, Karlstad Ø. Underlying conditions in adults with COVID-19. Tidsskr Nor Laegeforen. 2020;140(13):1340–5. doi:10.4045/tidsskr.20.0512.
   Web of Science ®Google Scholar
• Kutasi K, Koltai J, Szabo-Morvai A, Röst G, Karsai M, Biró P, Lengyel B. Understanding hesitancy with revealed preferences across COVID-19 vaccine types. Sci Rep. 2022;12(1):13293. doi:10.1038/s41598-022-15633-5.
   PubMed Web of Science ®Google Scholar
• Shah A, Coiado OC. COVID-19 vaccine and booster hesitation around the world: a literature review. Front Med (Lausanne). 2022;9:1054557. doi:10.3389/fmed.2022.1054557.
   PubMed Web of Science ®Google Scholar
• Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Bohm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018;13(12):e0208601. doi:10.1371/journal.pone.0208601.
   PubMed Web of Science ®Google Scholar
• Nilsen TS, Gulseth HL, Daae A, Indseth T. Coronavirus immunisation abroad among foreign-born persons in Norway. Tidsskr Nor Laegeforen. 2022;142(10). doi:10.4045/tidsskr.22.0052.
   Google Scholar